Ibrance (Palbociclib) Capsules


Medical Evidenceibrance
Generic name: Palbociclib.

Trade name: Ibrance.

Manufacturer information:

Ibrance is manufactured by Pfizer Inc.

Ibrance FDA Approval:

Ibrance first approved February 3rd, 2015.

Ibrance Dosage form:

Capsules: 75mg, 100mg, 125mg.

Ibrance Indications and Usage:

Breast Cancer:

  • Treatment of postmenopausal women with estrogen receptor (ER)-positive.
  • Human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based treatment for metastatic disease.

Ibrance (Palbociclib) Capsules availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.